Opportunities
SCM Lifesciences, equipped with the highest level of research, manufacturing, and quality control know-how, will provide new cell therapy products for the treatment of incurable diseases.
Cell Therapy
Way Maker
Securing cGMP and Global Pipeline simultaneously through mergers and acquisitions of Co-Immune and Formula through rapid decision-making
leading innovation
Securing iPSC Pipeline and Tissue
Engineering Conducting Cell Sheet research
source technology
through the layer separation method.
Isolation of high-purity and high-potency stem cells
reduction
3D Bioreactor Establishment of mass
production manufacturing process technology
-
152024.07
SCM Lifescience’s Atopic Therapy Published in Top Clinical Journal: Gr..
An article on the results of the Phase 1/2 clinical trial of SCM-AGH, a stem cell therapy developed for atopic dermatiti..
-
302024.04
SCM Lifescience, chosen for the 'autoimmune disease stem cell multi-pr..
- Research initiative for the 2024 Pan-Ministry Regenerative Medical Technology Development Project- Results of strategi..
-
112024.04
SCM LifeScience unveils Phase 1·2a results of 'Acute Pancreatitis Stem..
SCM LifeScience's Phase 1 and Phase 2a clinical trials in acute pancreatitis were presented at the prestigious Internati..
We will improve the value of your investment.